SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biocryst Pharmaceuticals Inc (BCRX)
An SI Board Since January 2004
Posts SubjectMarks Bans Symbol
269 15 0 BCRX
Emcee:  SemiBull Type:  Unmoderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
19Rick, There is an article in the November 14th Forbes that includes BioCryst, tShawn Donahue-11/9/2005
18>> should give you an idea of how I botched the scalp << It was a gscaram(o)uche-11/9/2005
17>> Yes, if I get an op to buy it back at $10, I may take it. << Thascaram(o)uche-11/9/2005
16>> Yes, if I get an op to buy it back at $10, I may take it. << Thascaram(o)uche-11/9/2005
15Manny: Thanks, hadn't noticed it coming back. Did the other avflu plays alscaram(o)uche-11/8/2005
14Richard, BCRX is getting hammered today.Are you still positive on its potentialmanny t-11/8/2005
13GlaxoSmithKline Announces Approval of ARRANON(R) (nelarabine) Injection Friday Oscaram(o)uche-10/28/2005
1214. ;-)scaram(o)uche-10/28/2005
1118. (eom)scaram(o)uche-10/17/2005
1016. :-) SPA filed for Frodo.scaram(o)uche-10/17/2005
917. (eom)scaram(o)uche-10/14/2005
816. (eom)scaram(o)uche-10/14/2005
7forbes.com Stock Of The Week Bird Flu High Flyer John Dobosz, 10.12.05, 9:15 scaram(o)uche-10/12/2005
6BVF sold out virtually all of it's holdings in November and December, FWIW: tuck-2/9/2004
5BioCryst Receives Orphan Drug Designation for BCX-1777 Thursday February 5, 7:5SemiBull-2/9/2004
4BioCryst Reports Fourth Quarter and Year-End 2003 Financial Results Wednesday FSemiBull-2/9/2004
3BioCryst Assigns Certain Rights from Complement Research to 3-Dimensional PharmaSemiBull-1/14/2004
2BioCryst Reviews Results of BCX-1777 Phase I Study in Aggressive T-Cell MalignanSemiBull-1/14/2004
1Biocryst files to offer $60 mln in common stock Tuesday December 16, 4:48 pm ETSemiBull-1/14/2004
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News